Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC raised its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 95.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 59,649 shares of the company's stock after purchasing an additional 29,204 shares during the quarter. Natixis Advisors LLC's holdings in Ryan Specialty were worth $3,827,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in RYAN. Rakuten Securities Inc. bought a new position in shares of Ryan Specialty in the 4th quarter worth $27,000. Principal Securities Inc. grew its position in Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after purchasing an additional 415 shares during the period. Quarry LP raised its stake in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after buying an additional 422 shares during the last quarter. Loomis Sayles & Co. L P grew its position in shares of Ryan Specialty by 26.3% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock valued at $91,000 after acquiring an additional 286 shares during the period. Finally, R Squared Ltd purchased a new stake in shares of Ryan Specialty in the fourth quarter valued at approximately $92,000. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Trading Down 1.4 %

RYAN stock traded down $1.04 on Wednesday, hitting $71.49. 557,213 shares of the company were exchanged, compared to its average volume of 962,213. The stock has a market capitalization of $18.72 billion, a price-to-earnings ratio of 103.61, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The business's fifty day moving average is $68.39 and its two-hundred day moving average is $68.13. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97.

Remove Ads

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. As a group, research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a dividend of $0.12 per share. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. This represents a $0.48 annualized dividend and a yield of 0.67%. Ryan Specialty's payout ratio is 69.57%.

Analyst Ratings Changes

A number of brokerages have recently commented on RYAN. UBS Group increased their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada reduced their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. Keefe, Bruyette & Woods decreased their target price on Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research note on Friday, February 21st. Wells Fargo & Company upped their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. Finally, Morgan Stanley initiated coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Ryan Specialty has a consensus rating of "Hold" and an average price target of $75.27.

Insider Activity

In other news, Director Nicholas Dominic Cortezi sold 29,466 shares of the firm's stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the completion of the sale, the director now owns 45,409 shares of the company's stock, valued at approximately $2,954,309.54. This trade represents a 39.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold 241,360 shares of company stock worth $16,006,428 over the last ninety days. Corporate insiders own 11.10% of the company's stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.